BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22015396)

  • 41. Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial.
    McTiernan A; Tworoger SS; Rajan KB; Yasui Y; Sorenson B; Ulrich CM; Chubak J; Stanczyk FZ; Bowen D; Irwin ML; Rudolph RE; Potter JD; Schwartz RS
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1099-105. PubMed ID: 15247119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
    Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Androgens and androgen receptors in breast cancer.
    Nicolás Díaz-Chico B; Germán Rodríguez F; González A; Ramírez R; Bilbao C; Cabrera de León A; Aguirre Jaime A; Chirino R; Navarro D; Díaz-Chico JC
    J Steroid Biochem Mol Biol; 2007; 105(1-5):1-15. PubMed ID: 17631997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early breast cancer detection.
    Foti E; Mancuso S
    Minerva Ginecol; 2005 Jun; 57(3):269-92. PubMed ID: 16166936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
    Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
    Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Androgens and estrogens in the etiology and prevention of breast cancer.
    Muti P; Rogan E; Cavalieri E
    Nutr Cancer; 2006; 56(2):247-52. PubMed ID: 17474872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Progesterone and breast cancer].
    Mansueto G; Mistretta V; Angeletti F; Trento LK; Angelozzi D; Bracaglia M; Pagliarella MR; Di Muccio L
    Recenti Prog Med; 2006; 97(7-8):376-80. PubMed ID: 16913172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Androgens and androgen receptor: do they play a role in breast cancer?
    Bryś M
    Med Sci Monit; 2000; 6(2):433-8. PubMed ID: 11208351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Steroids and receptors in canine mammary cancer.
    Illera JC; Pérez-Alenza MD; Nieto A; Jiménez MA; Silvan G; Dunner S; Peña L
    Steroids; 2006 Jul; 71(7):541-8. PubMed ID: 16631217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of dementia with sex hormones: a focus on testosterone and cognition in women.
    Hogervorst E
    Minerva Med; 2012 Oct; 103(5):353-9. PubMed ID: 23042370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Androgen receptors, serum androgen levels and survival of breast cancer patients.
    Langer M; Kubista E; Schemper M; Spona J
    Arch Gynecol Obstet; 1990; 247(4):203-9. PubMed ID: 2221994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testosterone and breast cancer.
    Hall SA; Araujo AB; Kupelian V; Maserejian NN; Travison TG
    J Sex Med; 2010 Feb; 7(2 Pt 2):1035-6; author reply 1036-7. PubMed ID: 19878445
    [No Abstract]   [Full Text] [Related]  

  • 54. Adrenal androgens and human breast cancer: a new appraisal.
    Adams JB
    Breast Cancer Res Treat; 1998 Sep; 51(2):183-8. PubMed ID: 9879779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The therapeutic use of androgens in women.
    Davis SR
    J Steroid Biochem Mol Biol; 1999; 69(1-6):177-84. PubMed ID: 10418991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient.
    Dizon DS; Tejada-Berges T; Koelliker S; Steinhoff M; Granai CO
    Gynecol Obstet Invest; 2006; 62(4):226-8. PubMed ID: 16804313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Androgens and mammary growth and neoplasia.
    Dimitrakakis C; Zhou J; Bondy CA
    Fertil Steril; 2002 Apr; 77 Suppl 4():S26-33. PubMed ID: 12007899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormone replacement therapy and mammographic density.
    Kilicdag EB; Bagis T; Pourbagher A; Tarim E
    Int J Gynaecol Obstet; 2004 Jul; 86(1):56-8. PubMed ID: 15207680
    [No Abstract]   [Full Text] [Related]  

  • 59. Androgens and cardiovascular disease in postmenopausal women: a systematic review.
    Spoletini I; Vitale C; Pelliccia F; Fossati C; Rosano GM
    Climacteric; 2014 Dec; 17(6):625-34. PubMed ID: 24559253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Androgens act synergistically to enhance estrogen-induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptor.
    Paliouras M; Diamandis EP
    Mol Oncol; 2008 Apr; 1(4):413-24. PubMed ID: 19383315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.